Biomedical research; what gets funded where?
作者信息
Adam Taghreed, Ralaidovy Ambinintsoa H, Swaminathan Soumya
机构信息
Science division, World Health Organization, avenue Appia 20, 1211 Geneva 27, Switzerland.
出版信息
Bull World Health Organ. 2019 Aug 1;97(8):516-516A. doi: 10.2471/BLT.19.240499.
Abstract
摘要
相似文献
1
Biomedical research; what gets funded where?
Bull World Health Organ. 2019 Aug 1;97(8):516-516A. doi: 10.2471/BLT.19.240499.
2
SARS-CoV-2 and Research Funding: Do No Harm.
Health Secur. 2020 May/Jun;18(3):260-261. doi: 10.1089/hs.2020.0053. Epub 2020 May 27.
3
'Riskiest ideas' win $50 million from Chan Zuckerberg Biohub.
Nature. 2017 Feb 8;542(7641):280-281. doi: 10.1038/nature.2017.21440.
4
[Analysis of projects funded by NSFC in field of processing Chinese materia medica in recent five years].
Zhongguo Zhong Yao Za Zhi. 2015 May;40(9):1639-43.
5
Think it through first: questions to consider in writing a successful grant application.
Pediatr Radiol. 2014 Dec;44(12):1507-11. doi: 10.1007/s00247-014-3053-6. Epub 2014 Nov 19.
6
Towards a global fund for the health MDGs?
Lancet. 2009 Oct 3;374(9696):1146. doi: 10.1016/S0140-6736(09)61740-2.
7
Silicon Valley Meets Biomedical Research in the Chan Zuckerberg Initiative.
Cell. 2017 May 18;169(5):767-769. doi: 10.1016/j.cell.2017.05.013.
8
Canadians baulk at reforms to health-research agency.
Nature. 2015 Apr 16;520(7547):272-3. doi: 10.1038/520272a.
9
Setting priorities for health research: lessons from low- and middle-income countries.
Bull World Health Organ. 2007 Apr;85(4):319-21. doi: 10.2471/blt.06.032375.
10
Is the debate between “nature vs. nurture” almost over?
Optom Vis Sci. 2012 Feb;89(2):245. doi: 10.1097/OPX.0b013e31824951e5.
引用本文的文献
1
Tracking global resources and capacity for health research: time to reassess strategies and investment decisions.
Health Res Policy Syst. 2023 Sep 11;21(1):93. doi: 10.1186/s12961-023-00979-7.
2
The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments.
Lancet Glob Health. 2020 Oct;8(10):e1295-e1304. doi: 10.1016/S2214-109X(20)30357-0.
3
Resource allocation for biomedical research: analysis of investments by major funders.
Health Res Policy Syst. 2020 Feb 17;18(1):20. doi: 10.1186/s12961-020-0532-0.
4
Limited alignment of publicly competitive disease funding with disease burden in Japan.
PLoS One. 2020 Feb 10;15(2):e0228542. doi: 10.1371/journal.pone.0228542. eCollection 2020.
Zotero 插件